Who is Galera Therapeutics?

Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutic candidates that have the potential to transform radiotherapy in cancer.

How much did Galera Therapeutics lose in 2023?

Galera reported a net loss of $ (59.1) million, or $ (1.33) per share, for the year ended December 31, 2023, compared to a net loss of $ (62.2) million, or $ (2.30) per share, for the year ended December 31, 2022. About Galera Therapeutics

Where is Galera headquartered?

Galera is headquartered in Malvern, PA. For more information, please visit www.galeratx.com. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.